{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:07:24Z","timestamp":1790680044482,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.yrtph.2022.105248","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T01:43:03Z","timestamp":1661132583000},"page":"105248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["How to resolve inconclusive predictions from defined approaches for skin sensitisation in OECD Guideline No. 497"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8350-6722","authenticated-orcid":false,"given":"Donna S.","family":"Macmillan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyn L.","family":"Chilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra S.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott N.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2022.105248_bib1","series-title":"Industrial Chemicals Act 2019","year":"2019"},{"key":"10.1016\/j.yrtph.2022.105248_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/toxsci\/kfaa048","article-title":"A next-generation risk assessment case study for coumarin in cosmetic products","volume":"176","author":"Baltazar","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2022.105248_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/DER.0000000000000003","article-title":"Categorization of chemicals according to their relative human skin sensitizing potency","volume":"25","author":"Basketter","year":"2014","journal-title":"Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105248_bib4","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/jat.3448","article-title":"A quantitative in silico model for predicting skin sensitization using a nearest neighbours approach within expert-derived structure\u2013activity alert spaces","volume":"37","author":"Canipa","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105248_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.tiv.2015.02.012","article-title":"Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay","volume":"29","author":"Cottrez","year":"2015","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.yrtph.2022.105248_bib7","series-title":"Factsheet 40 - Skin Sensitisers","year":"2003"},{"key":"10.1016\/j.yrtph.2022.105248_bib8","series-title":"Guidance on Information Requirements and Chemical Safety Assessment - Skin Sensitisation","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105248_bib9","series-title":"Regulation (EC) No 1907\/2006 of the European Parliament and of the Council of 18 December 2006 Concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)","year":"2006"},{"key":"10.1016\/j.yrtph.2022.105248_bib10","first-page":"L 342","article-title":"Regulation (EC) No 1223\/2009 of the European parliament and of the council of 30 November 2009 on cosmetic products","volume":"52","author":"European Union","year":"2009","journal-title":"Official Journal of the European Union"},{"key":"10.1016\/j.yrtph.2022.105248_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104721","article-title":"Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients","volume":"116","author":"Gilmour","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105248_bib12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/10408444.2018.1429385","article-title":"Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database","volume":"48","author":"Hoffmann","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105248_bib13","series-title":"Expansion of the Cosmetics Europe Skin Sensitisation Database with New Substances and PPRA Data","author":"Hoffmann","year":"2022"},{"key":"10.1016\/j.yrtph.2022.105248_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jat.4082","article-title":"Improving predictive capacity of the Amino acid Derivative Reactivity Assay test method for skin sensitization potential with an optimal molar concentration of test chemical solution","volume":"41","author":"Imamura","year":"2021","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105248_bib15","first-page":"515","article-title":"Evaluation of the GARD assay in a blind Cosmetics Europe study","volume":"34","author":"Johansson","year":"2017","journal-title":"ALTEX"},{"key":"10.1016\/j.yrtph.2022.105248_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10408444.2018.1429386","article-title":"Non-animal methods to predict skin sensitization (II): an assessment of defined approaches","volume":"48","author":"Kleinstreuer","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105248_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/aivt.2021.0003","article-title":"Assessing experimental uncertainty in defined approaches: borderline ranges for in chemico and in vitro skin sensitization methods determined from ring trial data","volume":"7","author":"Kolle","year":"2021","journal-title":"Appl. In Vitro Toxicol."},{"key":"10.1016\/j.yrtph.2022.105248_bib18","series-title":"Derek Nexus v6.1.0","year":"2020"},{"key":"10.1016\/j.yrtph.2022.105248_bib19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jat.3634","article-title":"Transferability and within- and between-laboratory reproducibilities of EpiSensA for predicting skin sensitization potential in vitro: a ring study in three laboratories","volume":"38","author":"Mizumachi","year":"2018","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105248_bib20","series-title":"Effects of Skin Contact with Chemicals Guidance for Occupational Health Professionals and Employers","year":"2020"},{"key":"10.1016\/j.yrtph.2022.105248_bib21","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.tiv.2007.03.016","article-title":"Utility and limitations of a peptide reactivity assay to predict fragrance allergens in vitro","volume":"21","author":"Natsch","year":"2007","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.yrtph.2022.105248_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/toxsci\/kfu229","article-title":"Predicting skin sensitizer potency based on in vitro data from KeratinoSens and kinetic peptide binding: global versus domain-based assessment","volume":"143","author":"Natsch","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2022.105248_bib23","first-page":"652","article-title":"Predictivity of the kinetic direct peptide reactivity assay (kDPRA) for sensitizer potency assessment and GHS subclassification","volume":"37","author":"Natsch","year":"2020","journal-title":"ALTEX"},{"key":"10.1016\/j.yrtph.2022.105248_bib25","series-title":"Test No. 406: Skin Sensitisation. OECD Guidelines for the Testing of Chemicals, Section 4","year":"1992"},{"key":"10.1016\/j.yrtph.2022.105248_bib26","series-title":"Test No. 429: Skin Sensitisation: Local Lymph Node Assay. OECD Guidelines for the Testing of Chemicals, Section 4","year":"2010"},{"key":"10.1016\/j.yrtph.2022.105248_bib27","series-title":"OECD Series on Testing and Assessment, No. 168. The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins","year":"2014"},{"key":"10.1016\/j.yrtph.2022.105248_bib28","author":"OECD","year":"2016"},{"key":"10.1016\/j.yrtph.2022.105248_bib29","series-title":"Test No. 442D: In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method. OECD Guidelines for the Testing of Chemicals, Section 4","year":"2018"},{"key":"10.1016\/j.yrtph.2022.105248_bib30","series-title":"Guideline No. 497: Defined Approaches on Skin Sensitisation. OECD Guidelines for the Testing of Chemicals, Section 4","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105248_bib31","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105248_bib32","series-title":"Series on Testing and Assessment No. 336: Supporting Document to the Guideline (GL) on Defined Approaches (DAs) for Skin Sensitisation","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105248_bib33","series-title":"Series on Testing and Assessment No. 337: Validation Study Report of the Kinetic Direct Peptide Reactivity Assay (kDPRA) in Test Guideline 442C","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105248_bib34","series-title":"Test No. 442C: In Chemico Skin Sensitisation: Assays addressing the Adverse Outcome Pathway key event on covalent binding to proteins. OECD Guidelines for the Testing of Chemicals, Section 4","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105248_bib35","series-title":"Mutual Acceptance of Data (MAD)","year":"2022"},{"key":"10.1016\/j.yrtph.2022.105248_bib36","series-title":"Test No. 442E: In Vitro Skin Sensitisation: In Vitro Skin Sensitisation assays addressing the Key Event on activation of dendritic cells on the Adverse Outcome Pathway for Skin Sensitisation. OECD Guidelines for the Testing of Chemicals, Section 4","year":"2022"},{"key":"10.1016\/j.yrtph.2022.105248_bib37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/10629360802083871","article-title":"An evaluation of the implementation of the Cramer classification scheme in the Toxtree software","volume":"19","author":"Patlewicz","year":"2008","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.yrtph.2022.105248_bib38","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.tiv.2015.03.009","article-title":"The Myeloid U937 Skin Sensitization Test (U-SENS) addresses the activation of dendritic cell event in the adverse outcome pathway for skin sensitization","volume":"29","author":"Piroird","year":"2015","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.yrtph.2022.105248_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/toxsci\/kfaa137","article-title":"Refinement of the peroxidase peptide reactivity assay and prediction model for assessing skin sensitization potential","volume":"178","author":"Ryan","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2022.105248_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tiv.2016.12.005","article-title":"An in vitro skin sensitization assay termed EpiSensA for broad sets of chemicals including lipophilic chemicals and pre\/pro-haptens","volume":"40","author":"Saito","year":"2017","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.yrtph.2022.105248_bib41","series-title":"Cruelty-Free Cosmetics Act (SB 1249)","author":"State of California","year":"2020"},{"key":"10.1016\/j.yrtph.2022.105248_bib42","series-title":"Cruelty-Free Cosmetic Act (SB 345 HD1)","author":"State of Hawaii","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105248_bib43","series-title":"(SB 0241)","author":"State of Illinois","year":"2020"},{"key":"10.1016\/j.yrtph.2022.105248_bib44","series-title":"Act to Ban the Sale of Cosmetics that Have Been Tested on Animals (LD 1551)","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105248_bib45","series-title":"Prohibition on Testing Cosmetics on Animals (SB 282)","author":"State of Maryland","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105248_bib46","series-title":"Nevada Cruelty Free Cosmetics Act (SB 197)","author":"State of Nevada","year":"2020"},{"key":"10.1016\/j.yrtph.2022.105248_bib47","series-title":"State of New Jersey","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105248_bib49","series-title":"The Congress of Colombia","year":"2020"},{"key":"10.1016\/j.yrtph.2022.105248_bib51","series-title":"Regulation (EC) No 1272\/2008 of the European Parliament and of the Council of 16 December 2008 on Classification, Labelling and Packaging","author":"European Union","year":"2008"},{"key":"10.1016\/j.yrtph.2022.105248_bib48","series-title":"Virginia Humane Cosmetics Act (SB 1379)","author":"State of Virginia","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105248_bib52","series-title":"Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Ninth Revised Edition","author":"United Nations","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105248_bib53","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.yrtph.2014.12.008","article-title":"Assessing skin sensitization hazard in mice and men using non-animal test methods","volume":"71","author":"Urbisch","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105248_bib5","series-title":"Title 15 - Commerce and Trade Chapter 53: Toxic Substances Control","year":"2016"},{"key":"10.1016\/j.yrtph.2022.105248_bib50","series-title":"The Frank R. Lautenberg Chemical Safety for the 21st Century Act","author":"US EPA","year":"2017"},{"key":"10.1016\/j.yrtph.2022.105248_bib54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.comtox.2019.01.006","article-title":"Automated and standardized workflows in the OECD QSAR Toolbox","volume":"10","author":"Yordanova","year":"2019","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105248_bib55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12016-018-8717-9","article-title":"Contact dermatitis to cosmetics","volume":"56","author":"Zirwas","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230022001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230022001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:33:11Z","timestamp":1759494791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230022001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":54,"alternative-id":["S0273230022001350"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2022.105248","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to resolve inconclusive predictions from defined approaches for skin sensitisation in OECD Guideline No. 497","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2022.105248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105248"}}